Doesn't matter if it's one pill a day or 3- Doesn't matter which drugs, their all approved now. Insurance cares about only 1 thing and that's price. They will only OK the cheaper rug.
Insider Trading Wire
DOUGLAS BRATTON K, of Buys $15,000,000 Worth of $JUNO – #Form4 #InsiderTrading
On 12/24/14, DOUGLAS BRATTON K, reported a net BUY trade of JUNO with a net transaction amountof $15,000,000. Net non-zero shares traded: 625000. See below for more information on with symbol JUNO traded on the Nasdaq NM. Original SEC Filing Period of Report: 2014-12-23
No offense doesn't matter what you think. Abbie is 12% cheaper than GILD. Black and white insurance Co going to OK Abbie drug and not GILD, that's what they do they will OK the cheaper drug and NOT ok the more expensive rug since they are both FDA approved.
@adamfeuerstein Jan 14th BLUE Webcasting #JPM15 Breakout Session / post.
2/19/2015 Citigroup Inc. Set Price Target Buy $132.00 View Tweet This Rating Share This Rating on StockTwits
2/18/2015 MLV & Co Boost Price Target Buy $123.00 - $130.00 View Tweet This Rating Share This Rating on StockTwits
2/17/2015 Canaccord Genuity Set Price Target Buy $163.00
BMO Capital Reiterates Bullish Take on ZIOPHARM (ZIOP) Following Meetings; Co. Considering Strategic Options as CAR-T Progresses
February 28, 2015 9:40 AM EST
BMO Capital analyst Jim Birchenough reiterated an Outperform rating onZIOPHARM Oncology (NASDAQ: ZIOP)